Clinical Trials Browser

Observational × Myeloproliferative Disorders × 30 days × Clear all

Myeloproliferative Disorders

NCT02402244 2026-02-27

Project: Every Child for Younger Patients With Cancer

CNSDermatologicEndocrineLymphoidMyeloidNETSarcoma

Carcinoma in Situ, Ganglioneuroma, Lymphoproliferative Disorders, Melanoma, Myeloproliferative Disorders, Neoplasms, Pheochromocytoma, Central Nervous System Neoplasms, Nephroma, Mesoblastic, Desmoid Tumors, Neuroendocrine Tumors

NCT06480591 2026-02-25

Evaluation of the Pathobiology of CALR-mutated MPN Cells

Recruiting

35 enrolled

Myeloid

Myeloproliferative Disorders, Thrombosis

NCT06131801 2026-02-18

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Recruiting

30 enrolled

LymphoidMyeloidOther hematologic neoplasm

Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01728402 2026-02-17

Pathogenesis of Hematologic Malignancies

Enrolling by invitation

5,000 enrolled

LymphoidMyeloid

Lymphoproliferative Disorders, Myelodysplastic Syndromes, Myeloproliferative Disorders

Clinical Trials

BioPredictor

Project: Every Child for Younger Patients With Cancer

Evaluation of the Pathobiology of CALR-mutated MPN Cells

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Pathogenesis of Hematologic Malignancies